8.81
price down icon14.88%   -1.54
after-market 시간 외 거래: 9.80 0.99 +11.24%
loading
전일 마감가:
$10.35
열려 있는:
$10.4
하루 거래량:
283.36K
Relative Volume:
1.78
시가총액:
$333.25M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-63.26%
1개월 성능:
+63.45%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
Value
$8.80
$10.75
1주일 범위
Value
$8.80
$22.71
52주 변동 폭
Value
$4.40
$33.66

Liminatus Pharma Inc Stock (LIMN) Company Profile

Name
명칭
Liminatus Pharma Inc
Name
전화
213-273-5453
Name
주소
6 CENTERPOINTE DR., LA PALMA
Name
직원
0
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
LIMN's Discussions on Twitter

LIMN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
LIMN
Liminatus Pharma Inc
8.81 333.25M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Liminatus Pharma Inc 주식(LIMN)의 최신 뉴스

pulisher
Jun 12, 2025

Why Is Liminatus Pharma Inc (LIMN) Up 83%? Unpacking the Surge - Wealth Daily

Jun 12, 2025
pulisher
Jun 12, 2025

KH Group's investment in US biotech Liminatus Pharma halves in one day - Chosun Biz

Jun 12, 2025
pulisher
Jun 08, 2025

Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN

Jun 08, 2025
pulisher
Jun 07, 2025

Liminatus Pharma stock gains on regaining compliance with Nasdaq - MSN

Jun 07, 2025
pulisher
Jun 05, 2025

Greif Posts Upbeat Earnings, Joins Planet Labs PBC, IperionX, Owens & Minor And Other Big Stocks Moving Higher On Thursday - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Crude Oil Moves Higher; Ciena Posts Downbeat Earnings - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Dow Dips Over 100 Points; US Jobless Claims Increase - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Liminatus Pharma shares soar on Nasdaq compliance news By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

Liminatus Pharma shares soar on Nasdaq compliance news - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews

Jun 05, 2025
pulisher
Jun 05, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Liminatus Pharma Gains Compliance With Nasdaq Filing Requirements; Shares up Pre-Bell - marketscreener.com

Jun 05, 2025
pulisher
Jun 04, 2025

Liminatus Pharma regains Nasdaq listing compliance - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Liminatus Pharma Regains Nasdaq Compliance After Filing Delay - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Liminatus Pharma, Inc.Class A Common Stock (Nasdaq:LIMN) Stock Quote - FinancialContent

Jun 04, 2025
pulisher
May 15, 2025

Liminatus Pharma Delays Quarterly Report Filing - TipRanks

May 15, 2025
pulisher
May 14, 2025

Liminatus Pharma’s Merger with Iris Acquisition Corp. - Global Legal Chronicle

May 14, 2025
pulisher
May 01, 2025

Iris Acquisition, Liminatus Pharma Sign SPAC Merger Deal - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

LIMN Stock Price and Chart — NASDAQ:LIMN - TradingView

May 01, 2025
pulisher
Mar 10, 2025

Iris Acquisition Corp confirms delisting and shareholder vote outcomes - Investing.com

Mar 10, 2025
pulisher
Jan 28, 2025

Iris Acquisition Corp announces preliminary proxy statement - Investing.com

Jan 28, 2025
pulisher
Nov 11, 2024

Iris Acquisition Corp announces business combination - Investing.com

Nov 11, 2024
pulisher
Aug 07, 2024

Iris Acquisition Corp announces business combination with Liminatus Pharma - Investing.com

Aug 07, 2024
pulisher
Dec 05, 2022

New company Liminatus Pharma Inc to develop three cancer treatments - Labiotech.eu

Dec 05, 2022
pulisher
Dec 02, 2022

A fledgling biotech goes SPAC route to bankroll cancer vaccine, CAR-T and CD47 - Endpoints News

Dec 02, 2022
pulisher
Dec 01, 2022

Liminatus Pharma and Iris Acquisition to Combine in $334M Deal - The SPAC Conference

Dec 01, 2022
pulisher
Nov 30, 2022

Liminatus Pharma and Iris Acquisition Corp to Combine - citybiz

Nov 30, 2022
pulisher
Mar 20, 2017

Holland & Knight Partner Seth Belzley Ranked Among Denver’s Outstanding "40 Under 40" Business Professionals - Holland & Knight

Mar 20, 2017

Liminatus Pharma Inc (LIMN) 재무 분석

Liminatus Pharma Inc (LIMN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):